The highest risk of death from prostate cancer is associated with increased waist circumference, increased blood pressure, hypertension, type 2 diabetes and obesity; thus, therapies that can reduce blood glucose levels have the potential to improve patient outcomes. The therapeutic benefits of low-carbohydrate and fasting-mimicking diets in patients with prostate cancer have been investigated in two recent studies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lavalette, C. et al. Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study. Oncotarget 9, 34485–34494 (2018).
Häggström, C. et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer 118, 6199–6206 (2012).
Geng, J.-H. et al. Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-022-00494-w (2022).
Mohamedali, H. Z., Breunis, H., Timilshina, N. & Alibhai, S. M. H. Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer. Can. Urol. Assoc. J. 5, 28–32 (2011).
Chi, J.-T. et al. Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-022-00525-6 (2022).
Seyfried, T. N., Arismendi-Morillo, G., Mukherjee, P. & Chinopoulos, C. On the origin of ATP synthesis in cancer. iScience 23, 101761 (2020).
Seyfried, T. N., Yu, G., Maroon, J. C. & D’Agostino, D. P. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutr. Metab. 14, 19 (2017).
Fay-Watt, V. et al. The impact of a fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer: a pilot implementation study. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-022-00528-3 (2022).
Vayalil, P. K. & Landar, A. Mitochondrial oncobioenergetic index: a potential biomarker to predict progression from indolent to aggressive prostate cancer. Oncotarget 6, 43065–43080 (2015).
Lopaschuk, G. D., Hess, D. A. & Verma, S. Ketones regulate endothelial homeostasis. Cell Metab. 34, 513–515 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Seyfried, T.N. The effects of diet on prostate cancer outcomes. Nat Rev Urol 19, 389–390 (2022). https://doi.org/10.1038/s41585-022-00612-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00612-2